Biosimilars have saved patients billions of dollars and are changing the treatment landscape. Here’s how.
This article is sponsored by Sandoz, a Novartis division, and global leader in generic pharmaceuticals and biosimilars.
When I started working in the health care industry over 25 years ago, I was compelled by a passion to make a difference and improve the lives of those around me. Ultimately, that mission …












![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)








![Safety-net dentistry restores human dignity for patients recovering from severe addiction [PODCAST]](https://kevinmd.com/wp-content/uploads/b3db3337-cf69-4a9b-ad93-f5c4c5d8d499-190x100.jpeg)